Company: CRNX
Filing Date: 2025-04-23
Form Type: DEF 14A
Source: 0000950170-25-057452
Chunk: 30

Company: Crinetics Pharmaceuticals, Inc.
Filing Date: 2025-04-23
Form: DEF 14A
Chunk 30
---
 purchase shares of our common stock having a value of $525,000 and $225,000 in restricted stock units, or RSUs, in each case, vesting over three years in three equal annual installments on each of the first three anniversaries of the grant date, subject to continuous service as a

<div align='center'>18</div>

director through each vesting date, and (5) each non-employee director who is serving on the board of directors as of the date of any annual meeting of our stockholders and has been serving as a non-employee director for at least six months as of the date of such meeting receives an annual grant of options to purchase shares of our common stock having a value of $350,000 and $150,000 in RSUs, in each case, vesting on the first to occur of the first anniversary date of grant or the next occurring annual meeting of our stockholders, subject to continuous service as a director through such vesting date. Our board of directors intends to continue to review the director compensation policy and may make adjustments from time to time to the cash and equity compensation paid to our non-employee directors based on market practices and the input of its independent compensation consultant. Compensation under our non-employee director compensation program is subject to the annual limits on non-employee director compensation set forth in our 2018 Incentive Award Plan, or the 2018 Plan. Specifically, the 2018 Plan provides that the sum of any cash compensation or other compensation and the grant date fair value (as determined in accordance with ASC 718, or any successor thereto) of any equity awards granted as compensation for services as a non-employee director during any fiscal year may not exceed $750,000, increased to $1,000,000 in the fiscal year of a non-employee director’s initial service as a non-employee director. Our board of directors or its authorized committee may modify the non-employee director compensation program from time to time in the exercise of its business judgment, taking into account such factors, circumstances and considerations as it shall deem relevant, subject to the annual limit on non-employee director compensation set forth in the 2018 Plan. As provided in the 2018 Plan, our board of directors or its authorized committee may make exceptions to this limit for individual non-employee directors in extraordinary circumstances, as the board of directors or its authorized committee may determine in its discretion, provided that the non-employee director receiving such additional compensation may not participate